This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cytori Therapeutics Announces Participation At The 2013 Stem Cell Meeting On The Mesa’s 3rd Annual Regen Med Partnering Forum On October 14th And 15th

Cytori Therapeutics, Inc. (NASDAQ: CYTX) will give a company presentation at the 3rd Annual Regen Med Partnering Forum, part of the 2013 Stem Cell Meeting on the Mesa on Tuesday, October 15. In addition, Cytori’s CEO Chris Calhoun will be participating on a conference panel on Monday, October 14.

The following are specific details regarding Cytori’s presentation and panel participation at the conference:


Panel III: Financing Regenerative Medicine & Advanced Therapies

  Date:     October 14, 2013
Time: 4:00 PM PT
Location: La Jolla Ballroom CD&E, Estancia La Jolla Hotel & Spa9700 North Torrey Pines Road, La Jolla, CA, 92037

Cytori Therapeutics, Inc. Company Presentation

Date: October 15, 2013
Time: 11:45 AM PT
Location: La Jolla Ballroom CD&E, Estancia La Jolla Hotel & Spa9700 North Torrey Pines Road, La Jolla, CA, 92037

Both the presentation and the panel will be available live and will be available on the Webcasts page of Cytori’s investor relations site approximately two weeks following the conference.

The 2013 Stem Cell Meeting on the Mesa conference is being organized by the Alliance for Regenerative Medicine (ARM), the California Institute for Regenerative Medicine and the Sanford Consortium for Regenerative Medicine with the intention of bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell science into cures.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs